Abstract
Nicotinic acid (NA) decreases low density lipoprotein (LDL) cholesterol and increases highdensity lipoprotein (HDL) cholesterol at pharmacological doses 500-2000 mg/day, which further inhibits the progression of atherosclerosis and cardiovascular morbidity. However, some effects of NA may be mediated through lipid-independent pathways. NA participates in the regulation of glucose metabolism and the NAD-sirtuin pathway, which may relate to the altered mitochondrial biogenesis. NA exerts its anti-atherosclerotic or side effects via binding to GPR109A and receptor TRPV1. NA may regulate lipid metabolism via adipokines, especially TNFα and adiponectin. NA participates in several cellular pathways, including forkhead transcription factors, sirtuins, and protein kinase B. Though much progress on the regulatory effect of NA has been obtained, much remains to be determined about the exact cellular signal pathways on the regulatory mechanism. To reveal the mechanisms of excessive fatty deposition diseases, it is necessary to investigate the signaling pathways in the muscle, liver, and adipose tissue by which NA controls lipid metabolism. In this paper, we will review recent data on the pharmacological effects of NA and discuss how NA might be harnessed to regulate glucose and lipid metabolism through lipid-independent pathways.
Keywords: Adipokine, glucose metabolism, lipid metabolism, nicotinic acid, nicotinamide, receptor GPR109A, regulatory mechanism.
Current Pharmaceutical Biotechnology
Title:Nicotinic Acid Regulates Glucose and Lipid Metabolism Through Lipidindependent Pathways
Volume: 16 Issue: 1
Author(s): Dongwu Liu, Xiaoqian Wang, Ling Kong and Zhiwei Chen
Affiliation:
Keywords: Adipokine, glucose metabolism, lipid metabolism, nicotinic acid, nicotinamide, receptor GPR109A, regulatory mechanism.
Abstract: Nicotinic acid (NA) decreases low density lipoprotein (LDL) cholesterol and increases highdensity lipoprotein (HDL) cholesterol at pharmacological doses 500-2000 mg/day, which further inhibits the progression of atherosclerosis and cardiovascular morbidity. However, some effects of NA may be mediated through lipid-independent pathways. NA participates in the regulation of glucose metabolism and the NAD-sirtuin pathway, which may relate to the altered mitochondrial biogenesis. NA exerts its anti-atherosclerotic or side effects via binding to GPR109A and receptor TRPV1. NA may regulate lipid metabolism via adipokines, especially TNFα and adiponectin. NA participates in several cellular pathways, including forkhead transcription factors, sirtuins, and protein kinase B. Though much progress on the regulatory effect of NA has been obtained, much remains to be determined about the exact cellular signal pathways on the regulatory mechanism. To reveal the mechanisms of excessive fatty deposition diseases, it is necessary to investigate the signaling pathways in the muscle, liver, and adipose tissue by which NA controls lipid metabolism. In this paper, we will review recent data on the pharmacological effects of NA and discuss how NA might be harnessed to regulate glucose and lipid metabolism through lipid-independent pathways.
Export Options
About this article
Cite this article as:
Liu Dongwu, Wang Xiaoqian, Kong Ling and Chen Zhiwei, Nicotinic Acid Regulates Glucose and Lipid Metabolism Through Lipidindependent Pathways, Current Pharmaceutical Biotechnology 2015; 16 (1) . https://dx.doi.org/10.2174/1389201015666141126123401
DOI https://dx.doi.org/10.2174/1389201015666141126123401 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Histone Deacetylase Inhibitors Target Diabetes via Chromatin Remodeling or as Chemical Chaperones?
Current Diabetes Reviews A Systemic Approach to Cancer Treatment: Tumor Cell Reprogramming Focused on Endocrine-Related Cancers
Current Medicinal Chemistry Ghrelin: New Insight to Mechanisms and Treatment of Postoperative Gastric Ileus
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Green Chemistry Patents on Enhancing the Potency and Longevity of Highly Valuable Protein Hormones
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Synthesis of 6-s-cis and 6-s-trans A-Ring Modified Vitamin D Analogues
Current Topics in Medicinal Chemistry The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
Current Pharmaceutical Biotechnology The Pleiotropic Effects of Inducible Nitric Oxide Synthase (iNOS) on the Physiology and Pathology of Penile Erection
Current Pharmaceutical Design Potential Clinical Applications of Multi-functional Milk Proteins and Peptides in Cancer Management
Current Medicinal Chemistry Pharmacoperones: A New Therapeutic Approach for Diseases Caused By Misfolded G Protein-Coupled Receptors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Emerging Anabolic Treatments in Osteoporosis
Current Drug Safety Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Endocrine, Metabolic & Immune Disorders - Drug Targets Carcinogenesis and Therapeutic Strategies in Thyroid Cancer
Current Drug Targets Relevance of the Neuropeptide Y System in the Biology of Cancer Progression
Current Topics in Medicinal Chemistry Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Protecting Endothelium in Cardiovascular Diseases
Current Medicinal Chemistry Structure and Function of the Human Nuclear Xenobiotic Receptor PXR
Current Drug Metabolism Treatment of Acute Hypercalcemia
Medicinal Chemistry Fighting Alzheimer's Disease and Type 2 Diabetes: Pathological links and Treatment Strategies
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Membrane Interacting Peptides: From Killers to Helpers
Current Protein & Peptide Science